{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T11:12:44Z","timestamp":1784718764838,"version":"3.55.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003172","name":"Henan University of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003172","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013066","name":"Key Scientific Research Project of Colleges and Universities in Henan Province","doi-asserted-by":"publisher","award":["23ZX006"],"award-info":[{"award-number":["23ZX006"]}],"id":[{"id":"10.13039\/501100013066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013066","name":"Key Scientific Research Project of Colleges and Universities in Henan Province","doi-asserted-by":"publisher","award":["Z20231811030"],"award-info":[{"award-number":["Z20231811030"]}],"id":[{"id":"10.13039\/501100013066","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bioorg.2025.109210","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T02:21:03Z","timestamp":1762482063000},"page":"109210","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["1,2,3-Triazole-modified sorafenib derivatives induce DNA damage, apoptosis, and PI3K\/AKT pathway suppression in hepatocellular carcinoma: Design, synthesis, and evaluation"],"prefix":"10.1016","volume":"167","author":[{"given":"Longfei","family":"Mao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmeng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xixi","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanqiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2025.109210_bb0005","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41392-024-02075-w","article-title":"Hepatocellular carcinoma: signaling pathways and therapeutic advances","volume":"10","author":"Zheng","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bioorg.2025.109210_bb0010","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s12943-024-02101-z","article-title":"Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma","volume":"23","author":"Chan","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bioorg.2025.109210_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217061","article-title":"Hepatocellular carcinoma and lipid metabolism: novel targets and therapeutic strategies","volume":"597","author":"Cao","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bioorg.2025.109210_bb0020","first-page":"228","article-title":"Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment","volume":"31","author":"Hwang","year":"2025","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.bioorg.2025.109210_bb0025","doi-asserted-by":"crossref","first-page":"11091","DOI":"10.3390\/ijms252011091","article-title":"Hepatocellular carcinoma immunotherapy: predictors of response, issues, and challenges","volume":"25","author":"Rizzo","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.109210_bb0030","first-page":"26","article-title":"Advances in immunotherapy in hepatocellular carcinoma","volume":"2025","author":"Bloom","year":"1936","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.109210_bb0035","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s10555-025-10251-9","article-title":"Mitochondrial alterations and signatures in hepatocellular carcinoma","volume":"44","author":"Chen","year":"2025","journal-title":"Cancer Metastasis Rev."},{"issue":"32","key":"10.1016\/j.bioorg.2025.109210_bb0040","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3390\/curroncol32010040","article-title":"Hepatocellular carcinoma. imaging advances in 2024 with a focus on magnetic resonance imaging","author":"Renzulli","year":"2025","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.bioorg.2025.109210_bb0045","doi-asserted-by":"crossref","first-page":"4972523","DOI":"10.1155\/2024\/4972523","article-title":"The role of Bcl-2 family proteins and Sorafenib resistance in hepatocellular carcinoma","volume":"2024","author":"de Melo Silva","year":"2024","journal-title":"Int. J. Cell Biol."},{"key":"10.1016\/j.bioorg.2025.109210_bb0050","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12943-024-02224-3","article-title":"CircTTC13 promotes sorafenib resistance in hepatocellular carcinoma through the inhibition of ferroptosis by targeting the miR-513a-5p\/SLC7A11 axis","volume":"24","author":"Zhang","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bioorg.2025.109210_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcmgh.2024.101454","article-title":"Sorafenib promotes Treg cell differentiation to compromise its efficacy via VEGFR\/AKT\/Foxo1 signaling in hepatocellular carcinoma","volume":"19","author":"Shen","year":"2025","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bioorg.2025.109210_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2025.189310","article-title":"Sorafenib resistance and therapeutic strategies in hepatocellular carcinoma","volume":"1880","author":"Zhang","year":"2025","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.bioorg.2025.109210_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114487","article-title":"Deubiquitylase OTUD3 regulates integrated stress response to suppress progression and sorafenib resistance of liver cancer","volume":"43","author":"Dai","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.bioorg.2025.109210_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114996","article-title":"Carbonic anhydrase 2 facilitates sorafenib resistance by counteracting MCT4-mediated intracellular pH dysregulation in HCC","volume":"43","author":"Lu","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.bioorg.2025.109210_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107490","article-title":"GSTA1\/CTNNB1 axis facilitates sorafenib resistance via suppressing ferroptosis in hepatocellular carcinoma","volume":"210","author":"Ma","year":"2024","journal-title":"Pharmacol. Res."},{"issue":"21","key":"10.1016\/j.bioorg.2025.109210_bb0080","doi-asserted-by":"crossref","first-page":"6549","DOI":"10.1016\/j.bmcl.2012.09.031","article-title":"Design, synthesis and biological activities of sorafenib derivatives as antitumor agents","volume":"22","author":"Yao","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.109210_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.110993","article-title":"Regorafenib promotes antitumor progression in melanoma by reducing RRM2","volume":"27","author":"Xuan","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.bioorg.2025.109210_bb0090","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.2169\/internalmedicine.2939-23","article-title":"Regorafenib-induced myopathy","volume":"63","author":"Ochiai","year":"2024","journal-title":"Internal Med. (Tokyo, Japan)"},{"key":"10.1016\/j.bioorg.2025.109210_bb0095","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2406936121","article-title":"TRIM21 induces selective autophagic degradation of c-Myc and sensitizes regorafenib therapy in colorectal cancer","volume":"121","author":"Ye","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bioorg.2025.109210_bb0100","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.cclet.2015.10.004","article-title":"Design, synthesis and biological evaluation of biphenylurea derivatives as VEGFR-2 kinase inhibitors (II)","volume":"27","author":"Gao","year":"2016","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.109210_bb0105","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1039\/D3MD00031A","article-title":"Antiproliferative activity and toxicity evaluation of 1,2,3-triazole and 4-methyl coumarin hybrids in the MCF7 breast cancer cell line","volume":"14","author":"Augsten","year":"2023","journal-title":"RSC Medicinal Chemistry"},{"key":"10.1016\/j.bioorg.2025.109210_bb0110","doi-asserted-by":"crossref","first-page":"7788","DOI":"10.1021\/acs.jmedchem.4c00652","article-title":"Triazoles in medicinal chemistry: physicochemical properties, Bioisosterism, and application","volume":"67","author":"Guan","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109210_bb0115","article-title":"Discovery of Icotinib-1,2,3-Triazole derivatives as IDO1 inhibitors","volume":"579024","author":"Mao","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.109210_bb0120","article-title":"1,2,3-Triazole-containing hybrids as potential anticancer agents: current developments, action mechanisms and structure-activity relationships","volume":"1","author":"Xu","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109210_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.138743","article-title":"Novel hybrid benzoisothiazole-1,2,3-triazole-4-carboxamides with sub-micromolar toxicity towards human breast carcinoma cells and high affinity to DNA","volume":"1314","author":"Pokhodylo","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2025.109210_bb0130","article-title":"Synthesis, antiproliferative activity and DNA\/RNA-binding properties of mono- and bis-(1,2,3-triazolyl)-appended benzimidazo[1,2-a] quinoline derivatives","volume":"185","author":"Macan","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109210_bb0135","doi-asserted-by":"crossref","first-page":"106926","DOI":"10.1016\/j.bioorg.2023.106926","article-title":"Discovery of dolutegravir-1,2,3-triazole derivatives against prostate cancer via inducing DNA damage. 2023","volume":"141","author":"Zhou","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.109210_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114633","article-title":"Novel N-(4-thiocyanatophenyl)-1H-1,2,3-triazole-4-carboxamides exhibit selective cytotoxic activity at nanomolar doses towards human leukemic T-cells","volume":"241","author":"Pokhodylo","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109210_bb0145","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1002\/cmdc.202100554","article-title":"Synthesis of Isocryptolepine-Triazole adducts and evaluation of their cytotoxic activity","volume":"16","author":"Rodphon","year":"2021","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2025.109210_bb0150","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1016\/j.bmcl.2016.07.053","article-title":"Synthesis and biological evaluation of some novel triazole hybrids of curcumin mimics and their selective anticancer activity against breast and prostate cancer cell lines","volume":"26","author":"Mandalapu","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.109210_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108159","article-title":"Design and synthesis of new 1,2,3-triazole derivatives as VEGFR-2\/telomerase downregulatory candidates endowed with apoptotic potential for cancer treatment","volume":"156","author":"Al-Karmalawy","year":"2025","journal-title":"Bioorg. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825010909?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825010909?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T01:46:55Z","timestamp":1766108815000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825010909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":31,"alternative-id":["S0045206825010909"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109210","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"1,2,3-Triazole-modified sorafenib derivatives induce DNA damage, apoptosis, and PI3K\/AKT pathway suppression in hepatocellular carcinoma: Design, synthesis, and evaluation","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109210","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109210"}}